Dracunculus medinensis

From WikiMD's WELLNESSPEDIA

Dracunculus medinensis is a parasitic worm that causes a condition known as dracunculiasis, or Guinea worm disease. This worm is the largest of the tissue parasite affecting humans. The adult female, which carries about 3 million embryos, can measure 600 to 800 mm in length and 2 mm in diameter. The males are much smaller (40 mm by 1 mm) and their lifespan is short.

Life Cycle[edit]

The life cycle of Dracunculus medinensis begins when a person drinks water contaminated with copepods (small crustaceans) that are infected with the larvae of the worm. The copepods die in the stomach, releasing the larvae, which penetrate the host's stomach or intestinal wall and enter the abdominal cavity and retroperitoneal space.

Over the next year, the female worm grows to a full size. When it is ready to release its larvae, it creates a painful blister in the skin, usually on the lower limbs. When the blister bursts, the female worm emerges and releases thousands of larvae. This is often accompanied by intense pain and a burning sensation.

Transmission[edit]

Transmission of Dracunculus medinensis occurs when larvae are released into water from the emerging female worm. The larvae are ingested by copepods and develop into infective larvae within the copepods. These copepods are then ingested by humans, and the cycle begins again.

Prevention and Control[edit]

Prevention and control of dracunculiasis involves providing safe drinking water; filtering water through a cloth if it is not known to be safe; and preventing people with emerging worms from entering water sources.

Treatment[edit]

There is no drug to treat dracunculiasis or vaccine to prevent infection. Once the worm begins to emerge, it can only be pulled out a few centimeters each day and wound around a small stick. This process, which is painful, can take weeks.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.